Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7227) 7227
Publication (1065) 1065
Book Review (163) 163
Book Chapter (84) 84
Newsletter (61) 61
Newspaper Article (37) 37
Book / eBook (31) 31
Conference Proceeding (16) 16
Dissertation (10) 10
Magazine Article (3) 3
Data Set (2) 2
Presentation (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5322) 5322
index medicus (3682) 3682
animals (2478) 2478
male (1998) 1998
female (1996) 1996
virology (1937) 1937
hepatitis (1904) 1904
viruses (1513) 1513
adult (1467) 1467
hepatitis b virus - pathogenicity (1440) 1440
middle aged (1398) 1398
hepacivirus - pathogenicity (1381) 1381
infection (1365) 1365
health aspects (1349) 1349
hepatitis c virus (1141) 1141
gastroenterology & hepatology (1084) 1084
infectious diseases (1063) 1063
infections (1037) 1037
virus diseases (975) 975
genotype (928) 928
microbiology (892) 892
hepatitis c (876) 876
immunology (871) 871
mice (855) 855
hepatitis b virus (852) 852
hepatitis b (766) 766
hepatitis b virus - genetics (764) 764
risk factors (751) 751
aged (745) 745
analysis (742) 742
hepacivirus - genetics (741) 741
liver (735) 735
research (716) 716
proteins (703) 703
research article (660) 660
antiviral agents - therapeutic use (610) 610
prevalence (588) 588
hepatitis-c virus (577) 577
medicine (574) 574
replication (571) 571
genetic aspects (570) 570
hepatocellular-carcinoma (557) 557
cell line (533) 533
virus replication (531) 531
interferon (526) 526
molecular sequence data (526) 526
digestive system diseases (525) 525
hepatitis c - virology (523) 523
rna (517) 517
epidemiology (485) 485
mutation (484) 484
polymerase chain reaction (450) 450
liver neoplasms - virology (448) 448
multidisciplinary sciences (448) 448
carcinoma, hepatocellular - virology (442) 442
disease (436) 436
adolescent (433) 433
genomes (429) 429
hepatitis b - virology (425) 425
hepatocellular carcinoma (422) 422
liver - pathology (416) 416
gene expression (411) 411
expression (406) 406
liver - virology (403) 403
phylogeny (392) 392
dna (385) 385
article (384) 384
base sequence (383) 383
hepatitis b virus - immunology (379) 379
science (377) 377
treatment outcome (374) 374
hiv (363) 363
pathogenesis (358) 358
liver diseases (356) 356
biology (351) 351
oncology (351) 351
viral load (350) 350
liver cancer (348) 348
biochemistry & molecular biology (345) 345
hepacivirus - immunology (344) 344
hcv (343) 343
host-pathogen interactions (337) 337
rna, viral - genetics (333) 333
genotypes (332) 332
cell biology (330) 330
antiviral agents (317) 317
development and progression (312) 312
virus (310) 310
cells (307) 307
antigens (305) 305
viral infections (305) 305
disease models, animal (303) 303
cancer (302) 302
apoptosis (300) 300
medicine, research & experimental (300) 300
hepatitis b, chronic - virology (299) 299
hepatitis c, chronic - virology (298) 298
dna, viral - genetics (294) 294
virulence (293) 293
signal transduction (292) 292
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7193) 7193
Russian (41) 41
French (38) 38
German (29) 29
Chinese (26) 26
Japanese (25) 25
Spanish (17) 17
Polish (16) 16
Italian (5) 5
Hungarian (4) 4
Bulgarian (3) 3
Korean (3) 3
Portuguese (3) 3
Turkish (3) 3
Czech (2) 2
Romanian (2) 2
Arabic (1) 1
Danish (1) 1
Dutch (1) 1
Lithuanian (1) 1
Norwegian (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Hepatitis B virus infection
by Liaw, Yun-Fan, Prof and Chu, Chia-Ming, Prof
Lancet, The, ISSN 0140-6736, 2009, Volume 373, Issue 9663, pp. 582 - 592
Summary Since the introduction of the hepatitis B vaccine and other preventive measures, the worldwide prevalence of hepatitis B infection has fallen. However,... 
Internal Medicine | CORE PROMOTER MUTATIONS | MEDICINE, GENERAL & INTERNAL | HEPATOCELLULAR-CARCINOMA | GENOTYPE-C | LIVER-DISEASE PROGRESSION | ACUTE VIRAL-HEPATITIS | E-ANTIGEN SEROCONVERSION | TERM-FOLLOW-UP | HBEAG-POSITIVE PATIENTS | LAMIVUDINE THERAPY | NATURAL-HISTORY | Prevalence | Antiviral Agents - therapeutic use | Hepatitis B virus - pathogenicity | Humans | Risk Factors | Interferon-alpha - therapeutic use | Carcinoma, Hepatocellular - virology | Antiviral Agents - administration & dosage | Hepatitis B, Chronic - prevention & control | Hepatitis B, Chronic - drug therapy | Hepatitis B Vaccines | Hepatitis B, Chronic - physiopathology | Carcinoma, Hepatocellular - etiology | Antiviral Agents - economics | Hepatitis B virus - immunology | Virus Replication - physiology | Prevention | Antiviral agents | Patient outcomes | Hepatitis B vaccine | Dosage and administration | Drug therapy | Health aspects | Risk factors | Hepatitis B | Hepatitis | Genotype & phenotype | Body fluids | Chemotherapy | Womens health | Human immunodeficiency virus--HIV | Mortality | Drug resistance | Tropical diseases | Virology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text American Gastroenterological Association Institute Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug Therapy
by Reddy, K. Rajender and Beavers, Kimberly L and Hammond, Sarah P and Lim, Joseph K and Falck-Ytter, Yngve T and American Gastroenterological Association Institute
Gastroenterology, ISSN 0016-5085, 2015, Volume 148, Issue 1, pp. 215 - 219
Gastroenterology and Hepatology | GASTROENTEROLOGY & HEPATOLOGY | Recurrence | Antiviral Agents - therapeutic use | Hepatitis B virus - pathogenicity | Humans | Hepatitis B - virology | Treatment Outcome | Biomarkers - blood | Viral Load | Hepatitis B Surface Antigens - blood | DNA, Viral - blood | Hepatitis B - diagnosis | Hepatitis B - immunology | Hepatitis B Antibodies - blood | Hepatitis B virus - drug effects | Virus Activation - drug effects | Hepatitis B - drug therapy | Hepatitis B virus - genetics | Immunosuppressive Agents - adverse effects | Hepatitis B - prevention & control | Hepatitis B virus - immunology | Prevention | Practice guidelines (Medicine) | Medical colleges | Hepatitis B
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Infectivity of human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion
by Kleinman, Steven H and Lelie, Nico and Busch, Michael P
Transfusion, ISSN 0041-1132, 11/2009, Volume 49, Issue 11, pp. 2454 - 2489
LOW-LEVEL VIREMIA | INJECTION-DRUG USERS | RAMP-UP STAGES | NUCLEIC-ACID | PRIMARY HIV-1 INFECTION | TRANSMITTED VIRAL-INFECTIONS | RED-BLOOD-CELLS | SURFACE-ANTIGEN | HEMATOLOGY | WINDOW-PERIOD | HBV INFECTION | HIV-1 - pathogenicity | Hepatitis B virus - pathogenicity | Models, Biological | Humans | HIV Infections - transmission | Hepacivirus - pathogenicity | Hepatitis C - transmission | Hepatitis B - transmission | Transfusion Reaction | Hepatitis C | HIV (Viruses) | Hepatitis B
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Hepatitis B virus genotypes:Global distribution and clinical importance
by Mustafa Sunbul
世界胃肠病学杂志：英文版（电子版）, ISSN 1007-9327, 2014, Volume 20, Issue 18, pp. 5427 - 5434
At least 600000 individuals worldwide annually die of hepatitis B virus(HBV)-related diseases,such as chronic hepatitis B(CHB),liver cirrhosis(LC),and... 
Hepatitis | B | Chronic | virus | An | Genotypes | Hepatitis B virus | Viral mutation | Anti-viral therapy | Chronic hepatitis B | RISK-FACTORS | BASAL CORE PROMOTER | HBV GENOTYPES | CHRONIC LIVER-DISEASE | PREVALENCE | HEPATOCELLULAR-CARCINOMA | MOLECULAR EPIDEMIOLOGY | NEGATIVE INFECTION | MUTATIONS | EASTERN INDIA | GASTROENTEROLOGY & HEPATOLOGY | Global Health | Antiviral Agents - therapeutic use | Hepatitis B virus - pathogenicity | Humans | Drug Resistance, Viral | Hepatitis B - virology | Genotype | Hepatitis B - epidemiology | Treatment Outcome | Biomarkers - blood | Hepatitis B Surface Antigens - blood | Hepatitis B - diagnosis | Hepatitis B - immunology | Hepatitis B virus - drug effects | Phenotype | Hepatitis B - drug therapy | Hepatitis B virus - genetics | Hepatitis B e Antigens - blood | Hepatitis B virus - immunology | Topic Highlight
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Strategies to Inhibit Entry of HBV and HDV Into Hepatocytes
by Urban, Stephan and Bartenschlager, Ralf and Kubitz, Ralf and Zoulim, Fabien
Gastroenterology, ISSN 0016-5085, 2014, Volume 147, Issue 1, pp. 48 - 64
Although there has been much research into the pathogenesis and treatment of hepatitis B virus (HBV) and hepatitis D virus (HDV) infections, we still do not... 
Gastroenterology and Hepatology | Hepatitis B Virus Receptor | Sodium Taurocholate Cotransporting Polypeptide | SCL10A1 | SMALL HETERODIMER PARTNER | HEPATITIS-B-VIRUS | LARGE SURFACE PROTEIN | LARGE ENVELOPE PROTEIN | HEPATOBILIARY TRANSPORTER EXPRESSION | IN-VITRO | ADULT HUMAN HEPATOCYTES | MOUSE MODEL | HUMAN LIVER | MONOCLONAL-ANTIBODIES | GASTROENTEROLOGY & HEPATOLOGY | Viral Envelope Proteins - physiology | Antiviral Agents - pharmacology | Antiviral Agents - therapeutic use | Hepatitis B virus - pathogenicity | Hepatitis D - physiopathology | Hepatitis Delta Virus - physiology | Humans | Hepatocytes - pathology | Hepatitis Delta Virus - pathogenicity | Virus Internalization - drug effects | Hepatitis B virus - physiology | Hepatitis B - physiopathology | Hepatitis D - drug therapy | Animals | Cell Membrane Permeability - physiology | Cell Membrane Permeability - drug effects | Hepatitis B - drug therapy | Hepatocytes - virology | Hepatocytes - drug effects | Disease Models, Animal | Heparan Sulfate Proteoglycans - physiology | Sulfates | Health aspects | Protein binding | Hepatitis B
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text American Gastroenterological Association Institute Technical Review on Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug Therapy
by Perrillo, Robert P and Gish, Robert and Falck-Ytter, Yngve T
Gastroenterology, ISSN 0016-5085, 2015, Volume 148, Issue 1, pp. 221 - 244.e3
Gastroenterology and Hepatology | DOSE METHOTREXATE THERAPY | INFLAMMATORY-BOWEL-DISEASE | RECEIVING CYTOTOXIC CHEMOTHERAPY | HBV REACTIVATION | CHRONIC ACTIVE HEPATITIS | ARTERIAL CHEMOEMBOLIZATION THERAPY | BREAST-CANCER PATIENTS | HBSAG-NEGATIVE PATIENTS | NON-HODGKINS-LYMPHOMA | GASTROENTEROLOGY & HEPATOLOGY | TASK-FORCE RECOMMENDATION | Recurrence | Antiviral Agents - therapeutic use | Hepatitis B virus - pathogenicity | Humans | Risk Factors | Hepatitis B - virology | Treatment Outcome | Biomarkers - blood | Viral Load | Hepatitis B Surface Antigens - blood | DNA, Viral - blood | Hepatitis B - diagnosis | Hepatitis B - immunology | Hepatitis B Antibodies - blood | Hepatitis B virus - drug effects | Societies, Medical | Virus Activation - drug effects | Gastroenterology | Hepatitis B - drug therapy | Hepatitis B virus - genetics | Immunosuppressive Agents - adverse effects | Hepatitis B - prevention & control | Hepatitis B virus - immunology | Prevention | Continuing medical education | Hepatitis B
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text A targeted functional RNA interference screen uncovers glypican 5 as an entry factor for hepatitis B and D viruses
by Verrier, Eloi R and Colpitts, Che C and Bach, Charlotte and Heydmann, Laura and Weiss, Amélie and Renaud, Mickaël and Durand, Sarah C and Habersetzer, François and Durantel, David and Abou‐Jaoudé, Georges and López Ledesma, Maria M and Felmlee, Daniel J and Soumillon, Magali and Croonenborghs, Tom and Pochet, Nathalie and Nassal, Michael and Schuster, Catherine and Brino, Laurent and Sureau, Camille and Zeisel, Mirjam B and Baumert, Thomas F
Hepatology, ISSN 0270-9139, 01/2016, Volume 63, Issue 1, pp. 35 - 48
Chronic hepatitis B and D infections are major causes of liver disease and hepatocellular carcinoma worldwide. Efficient therapeutic approaches for cure are... 
PRIMARY TUPAIA HEPATOCYTES | CELLS | INHIBITOR MYRCLUDEX-B | CYCLOSPORINE-A | RECEPTOR | C VIRUS | MEMBRANE TRANSPORTER | INFECTION | HEPARAN-SULFATE PROTEOGLYCANS | GASTROENTEROLOGY & HEPATOLOGY | BINDING | Glypicans - physiology | Hepatitis B virus - pathogenicity | Humans | Cells, Cultured | RNA, Untranslated - physiology | Hepatitis Delta Virus - pathogenicity | Virus Internalization | Cell division | Hepatitis | Liver diseases | Liver | Bile | Cell culture | RNA-mediated interference | Hepatocellular carcinoma | Viruses | Liver cancer | Hepatocytes | Sodium | Heparan sulfate proteoglycans | Hepatitis B | Hepatitis delta virus | Life Sciences | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Hepatitis viruses and non-Hodgkin lymphoma: Epidemiology, mechanisms of tumorigenesis, and therapeutic opportunities
by Marcucci, Fabrizio and Mele, Alfonso
Blood, ISSN 0006-4971, 02/2011, Volume 117, Issue 6, pp. 1792 - 1798
Over the past 2 decades considerable evidence has accumulated on the association between hepatitis C virus (HCV) and hepatitis B virus (HBV) and several... 
B-CELL | ANTIVIRAL THERAPY | MALIGNANT-LYMPHOMA | IMMUNOGLOBULIN GENE REARRANGEMENT | C-VIRUS | FOLLICULAR LYMPHOMA | ENVELOPE PROTEIN | HEMATOLOGY | MIXED CRYOGLOBULINEMIA | BLOOD MONONUCLEAR-CELLS | LYMPHOPROLIFERATIVE DISEASES | Hepatitis B virus - pathogenicity | Lymphoma, Non-Hodgkin - therapy | Lymphoma, Non-Hodgkin - virology | Models, Biological | Humans | Hepacivirus - pathogenicity | Cryoglobulinemia - etiology | Lymphoma, Non-Hodgkin - epidemiology | Hematologic Neoplasms - etiology | Oncogenic Viruses - pathogenicity | Lymphoma, Non-Hodgkin - etiology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor
by Nkongolo, Shirin and Ni, Yi and Lempp, Florian A and Kaufman, Christina and Lindner, Thomas and Esser-Nobis, Katharina and Lohmann, Volker and Mier, Walter and Mehrle, Stefan and Urban, Stephan
Journal of Hepatology, ISSN 0168-8278, 2013, Volume 60, Issue 4, pp. 723 - 731
Background & Aims Chronic hepatitis B and hepatitis D are global health problems caused by the human hepatitis B and hepatitis D virus. The myristoylated preS1... 
Gastroenterology and Hepatology | Viral entry | Immunosuppressive | Sodium taurocholate cotransporting polypeptide | Tacrolimus | Myrcludex B | Cyclosporin A | Hepatitis D | Binding domain | Hepatitis B | HEPATOCYTES | LIVER-TRANSPLANTATION | PROTEIN | DETERMINANTS | CHOLESTASIS | INFECTIVITY | TAUROCHOLATE COTRANSPORTING POLYPEPTIDE | TRANSPORT | REPLICATION | C VIRUS | GASTROENTEROLOGY & HEPATOLOGY | Cyclosporine - pharmacology | Hepatitis B virus - pathogenicity | Lipopeptides - pharmacology | Humans | Host-Pathogen Interactions - drug effects | Hepatitis Delta Virus - pathogenicity | Virus Internalization - drug effects | Organic Anion Transporters, Sodium-Dependent - genetics | Genetic Variation | Cyclophilins - pharmacology | Symporters - antagonists & inhibitors | Tacrolimus - pharmacology | Hepatitis Delta Virus - drug effects | Mutant Proteins - antagonists & inhibitors | Protein Structure, Tertiary | Cell Line | Hepatitis Delta Virus - physiology | Organic Anion Transporters, Sodium-Dependent - antagonists & inhibitors | Cells, Cultured | Mutant Proteins - genetics | Mutant Proteins - metabolism | Binding Sites - genetics | Hepatitis B virus - physiology | Symporters - metabolism | Hep G2 Cells | Hepatitis B virus - drug effects | Symporters - genetics | Cell Line, Tumor | Organic Anion Transporters, Sodium-Dependent - metabolism | Host-Pathogen Interactions - physiology | Cyclosporine | Protein binding | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights